Hill Colin 4
4 · Fulcrum Therapeutics, Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Hill Colin
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-17+60,000→ 60,000 totalExercise: $7.00Exp: 2034-06-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 17, 2024 and is scheduled to vest in equal monthly installments until June 17, 2027, subject to continued service.